In conclusion, ZKSCAN3 is a key driver of hepatocellular carcinoma progression through the integration of multiple mechanisms, including EMT signaling activation, epigenetic imbalance, autophagy inhibition, and chemoresistance, providing a multidimensional entry point for the development of targeted intervention strategies. This evidence concerns the gene ZKSCAN3 and hepatocellular carcinoma.